Merrimack Announces Timing of Third Quarter 2017 Investor Conference Call

Wednesday, November 1, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CAMBRIDGE, Mass., Nov. 1, 2017 /PRNewswire/ --Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that the company

will host its third quarter 2017 investor conference call and webcast at8:30 am ET onWednesday, November 8, 2017.

The call will cover an update on Merrimack's recent progress as well as a summary of third quarter 2017 financial results.

A press release detailing the information to be discussed on the call will be issued the morning of Wednesday, November 8, 2017. Investors and the general public are invited to listen to the call by dialing (877) 564-1301 (domestic) or (224) 357-2394 (international) five minutes prior to the start of the call and providing the passcode 6187659.

A listen-only webcast of the call will be available in the Investors section of Merrimack's website, investors.merrimack.com, and a replay of the call will be archived there for six weeks.

About MerrimackMerrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more information, please visit Merrimack's website at www.merrimack.com.

Forward-Looking StatementsAny statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.

CONTACT:

Geoffrey M. Grande, CFA617-441-7602 [email protected]

View original content:http://www.prnewswire.com/news-releases/merrimack-announces-timing-of-third-quarter-2017-investor-conference-call-300546454.html

SOURCE Merrimack Pharmaceuticals, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store